Human Primary Cells Market By Type (Epithelial Cells, Fibroblasts, Hematopoietic, Liver Cells, Mesenchymal Stem Cells, Pericytes ), By Application (Medical, Scientific Research ), Industry Analysis, COVID-19 Impact Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2028

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 180
The global Human Primary Cells market size is estimated at 7.80 billion USD with a CAGR of 10.8% during the forecasted period from 2021-2028.

The global Human Primary Cells market size is estimated at 7.80 billion USD with a CAGR of 10.8% during the forecasted period from 2021-2028. Cells that are cultured directly after isolation from normal or diseased human tissues are referred to Human Primary Cells. They are highly beneficial for research & development activities and are widely used for drug metabolism, proteomics, genomics, cancer studies, etc. The key factor driving the growth of Human Primary Cells market is attributed to increasing prevalence of cancer In addition, soaring funds in biomedical research along with growing demand for innovative drug development is contributing to the market growth. Moreover, expansion of pharmaceutical and biotechnology companies is ultimately demanding human primary cells for a wide range of applications such as drug discovery & testing, R&D, and so on. Also, strict guidelines concerning animal testing along with budding applications in genetic engineering to bloom the growth of this market. Furthermore, upsurge in stem cell therapy is increasing the demand for primary cells which is estimated to offer growth opportunities during the forecast period. Besides, COVID-19 pandemic is having a positive impact on the growth of this market. There is a surging use of primary cell culture by researchers for studying the infection and to produce antibodies and antigens for the COVID-19 virus. On the other hand, factors such as high cost and lack of skilled professional is projected to limit the growth of this market.

Market Determinants

The advent of newer technologies such as 3D culture, the use of primary cells are becoming increasingly prevalent to achieve improved results. The rapid growth in biotechnology and biopharmaceutical industries is slated to be the major driving force for the growth of human primary cell market. The Increasing research on personalized therapies and stem cells is fueling the growth of the market. Moreover, surge in the number of organ transplants and biobanking of cells, tissues and organs is driving growth of the market.

Human Primary Cells Market Segmentation

By Type • Epithelial Cells • Fibroblasts • Hematopoietic • Liver Cells • Mesenchymal Stem Cells • Muscle Cells • Pericytes By Application • Medical Research • Clinical Research • Other By Geography • North America • Europe • China • Japan • South-East Asia • India

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. HUMAN PRIMARY CELLS MARKET OVERVIEW 2.1. PRODUCT OVERVIEW 2.2. HUMAN PRIMARY CELLS SEGMENT BY TYPE (PRODUCT CATEGORY) 2.2.1. Global Human Primary Cells Production and CAGR (%) Comparison by Type (Product Category)(2017-2025) 2.2.2. Global Human Primary Cells Production Market Share by Type (Product Category) in 2017 2.2.3. Epithelial Cells 2.2.4. Fibroblasts 2.2.5. Hematopoietic 2.2.6. Liver Cells 2.2.7. Mesenchymal Stem Cells 2.2.8. Muscle Cells 2.2.9. Pericytes 2.3. GLOBAL HUMAN PRIMARY CELLS SEGMENT BY APPLICATION 2.3.1. Human Primary Cells Consumption (Sales) Comparison by Application (2017-2025) 2.3.2. Medical Research 2.3.3. Clinical Research 2.4. GLOBAL HUMAN PRIMARY CELLS MARKET BY REGION (2017-2025) 2.4.1. Global Human Primary Cells Market by region (2017-2025) 2.4.2. U.S. Status and Prospect (2017-2025) 2.4.3. Europe Status and Prospect (2017-2025) 2.4.4. China Status and Prospect (2017-2025) 2.4.5. Japan Status and Prospect (2017-2025) 2.4.6. Southeast Asia Status and Prospect (2017-2025) 2.4.7. India Status and Prospect (2017-2025) 2.5. GLOBAL HUMAN PRIMARY CELLS (2017-2025), PRODUCTION AND CAPACITY ANALYSIS 2.5.1. Production and capacity comparison by region (2017-2025) CHAPTER 3. GLOBAL HUMAN PRIMARY CELLS MARKET PLAYER ANALYSIS 3.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY MANUFACTURERS (2016-2017) 3.1. GLOBAL HUMAN PRIMARY CELLS RVENUE AND MARKET SHARE BY MANUFACTURERS (2016-2017) 3.1. GLOBAL HUMAN PRIMARY CELLS TOP FIVE MANUFACTURERS MARKET SHARE (2016-2017) CHAPTER 4. GLOBAL HUMAN PRIMARY CELLS PRODUCTION (VOLUME), REVENUE (VALUE) BY REGION (2017-2025) 4.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY REGION (2017-2025) 4.2. GLOBAL HUMAN PRIMARY CELLS REVENUE (VALUE) AND MARKET SHARE BY REGION (2017-2025) 4.3. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) 4.4. U.S. HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) 4.5. EUROPE HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) 4.6. CHINA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) 4.7. JAPAN HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) 4.8. SOUTHEAST ASIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) 4.9. INDIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) CHAPTER 5. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY REGION (2017-2025) 5.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY REGION (2017-2025) 5.2. U.S. HUMAN PRIMARY CELLS PRODUCTION (2017-2025) 5.3. EUROPE HUMAN PRIMARY CELLS PRODUCTION (2017-2025) 5.4. CHINA HUMAN PRIMARY CELLS PRODUCTION (2017-2025) 5.5. JAPAN HUMAN PRIMARY CELLS PRODUCTION (2017-2025) 5.6. SOUTHEAST ASIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025) 5.7. INDIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025) CHAPTER 6. GLOBAL HUMAN PRIMARY CELLS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE 6.1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY TYPE (2017-2025) 6.2. GLOBAL HUMAN PRIMARY CELLS REVENUE AND MARKET SHARE BY TYPE (2017-2025) 6.3. GLOBAL HUMAN PRIMARY CELLS PRODUCTION GROWTH BY TYPE (2017-2025) CHAPTER 7. GLOBAL HUMAN PRIMARY CELLS MARKET ANALYSIS BY APPLICATION 7.1. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION AND MARKET SHARE BY APPLICATION (2017-2025) 7.2. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION GROWTH RATE BY APPLICATION (2017-2025) 7.3. MARKET DRIVERS 7.3.1. Potential Applications CHAPTER 8. GLOBAL HUMAN PRIMARY CELLS MANUFACTURERS PROFILES/ANALYSIS 8.1. LONZA 8.1.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.1.2. Human Primary Cells Product Category, Application and Specification 8.1.2.1. Clonetics™ Normal Human Articular Chondrocytes (NHAC-kn) 8.1.2.2. Hepatocytes & Media 8.1.2.2.1. Fresh Human Hepatocytes 8.1.2.2.2. Cryopreserved Human Hepatocytes 8.1.3. Lonza Human Primary Cells Capacity, Production, Revenue, Price and Gross Margin (2017-2025) 8.1.4. Main Business/Business OverviewCompany Profile 8.2. THERMO FISHER SCIENTIFIC 8.2.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.2.2. Human Primary Cells Product Category, Application and Specification 8.2.2.1. Human Mammary Epithelial Cells (HMEC) 8.2.2.2. Human Umbilical Vein Endothelial Cells (HUVEC ) 8.2.3. Thermo Fisher Scientific Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025) 8.2.4. Main Business/Business Overview 8.3. SIGMA-ALDRICH 8.3.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.3.2. Human Primary Cells Product Category, Application and Specification 8.3.2.1. MTOXH1002 (Cryoplateable Primary Human Hepatocytes) 8.3.2.2. MTOXH1012 (Cryopreserved Primary Human Hepatocytes Juvenile) 8.3.3. Sigma-Aldrich Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025) 8.3.4. Main Business/Business Overview 8.4. CELL BIOLOGICS 8.4.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.4.2. Human Primary Cells Product Category, Application and Specification 8.4.2.1. HUMAN PRIMARY AORTIC ENDOTHELIAL CELLS 8.4.2.2. HUMAN PRIMARY AORTIC FIBROBLASTS 8.4.3. Main Business/Business Overview 8.5. PROMOCELL GMBH 8.5.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.5.2. Human Primary Cells Product Category, Application and Specification 8.5.2.1. Melanocytes 8.5.2.2. Cardiac Myocytes 8.5.3. Main Business/Business Overview 8.6. CURELINE 8.6.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.6.2. Human Primary Cells Product Category, Application and Specification 8.6.2.1. Spleen Primary Cell Line 8.6.3. Cureline Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025) 8.6.4. Main Business/Business Overview 8.7. ZEN-BIO 8.7.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.7.2. Human Primary Cells Product Category, Application and Specification 8.7.2.1. Human Adult Melanocytes 8.7.2.2. Adult Stem Cells 8.7.3. Main Business/Business Overview 8.8. STEMCELL TECHNOLOGIES 8.8.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.8.2. Human Primary Cells Product Category, Application and Specification 8.8.2.1. Human Peripheral Blood Monocytes 8.8.2.2. Human Platelet Lysate, Fibrinogen-Depleted 8.8.3. STEMCELL Technologies Human Primary Cells Production, Revenue, Price and Gross Margin (2017-2025) 8.8.4. Main Business/Business Overview 8.9. CELL APPLICATIONS 8.9.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.9.2. Human Primary Cells Product Category, Application and Specification 8.9.2.1. Human Hair Follicle Dermal Papilla Cells 8.9.2.2. Chondrocyte 8.9.3. Main Business/Business Overview 8.10. PELOBIOTECH 8.10.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area and Its Competitors 8.10.2. Human Primary Cells Product Category, Application and Specification 8.10.2.1. Human Basal Cell Carcinoma Primary Cell Culture – Frozen Vial 8.10.2.2. Human Brain Endothelial Primary Cell Culture Serum Free Media 8.10.3. Main Business/Business Overview 8.11. CREATIVE BIOARRAY 8.11.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors 8.11.2. Human Primary Cells Product Category, Application And Specification 8.11.2.1. Human Synovial Membrane Fibroblasts 8.11.2.2. Human Leptomeningeal Pericytes 8.11.3. Business Overview 8.12. CHARLES RIVER LABORATORIES 8.12.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors 8.12.2. Charles River Laboratories HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025) 8.12.3. Business Overview 8.13. AXOL BIOSCIENCE 8.13.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors 8.13.2. Human Primary Cells Product Category, Application And Specification 8.13.2.1. PRIMARY ENDOTHELIAL CELLS 8.13.2.2. DENTAL PULP STEM CELLS 8.13.3. Business Overview 8.14. REACHBIO RESEARCH LABS 8.14.1. Introduction, Geographical Presence, Manufacturing Base, Sales Area And Its Competitors 8.14.2. Human Primary Cells Product Category, Application And Specification 8.14.2.1. Human Peripheral Blood Mononuclear Cells (PBMCs) – Light Density 8.14.2.2. Human Cord Blood MNCs 8.14.3. Business Overview CHAPTER 9. HUMAN PRIMARY CELLS VALUE CHAIN ANALYSIS 9.1. HUMAN PRIMARY CELLS KEY RAW MATERIALS ANALYSIS 9.1.1. Bargaining power of suppliers 9.1.2. Key Suppliers of Raw Materials 9.2. MANUFACTURING PROCESS ANALYSIS OF HUMAN PRIMARY CELLS CHAPTER 10. INDUSTRIAL CHAIN, SOURCING STRATEGY 10.2. HUMAN PRIMARY CELLS MAJOR MANUFACTURERS IN 2017 10.3. CUSTOMER ANALYSIS CHAPTER 11. MARKET ENTRY & SALES STRATEGY 11.1. ENTRY STRATEGY 11.2. SALES AND MARKETING 11.3. PRICING STRATEGY CHAPTER 12. GLOBAL HUMAN PRIMARY CELLS MARKET HISTORICAL DATA (2014-2016) 12.1. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE HISTORICAL DATA (2014-2016) 12.1.1. Global Human Primary Cells Capacity, Production and Growth Rate (2014-2016) 12.1.2. Global Human Primary Cells Revenue and Growth Rate (2014-2016) 12.1.3. Global Human Primary Cells Price and Trend (2014-2016) 12.2. GLOBAL HUMAN PRIMARY CELLS PRODUCTION HISTORICAL DATA BY REGION (2014-2016) 12.2.1. U.S. Human Primary Cells Production, Revenue (2014-2016) 12.2.2. Europe Human Primary Cells Production, Revenue (2014-2016) 12.2.3. China Human Primary Cells Production, Revenue (2014-2016) 12.2.4. Japan Human Primary Cells Production, Revenue (2014-2016) 12.2.5. Southeast Asia Human Primary Cells Production, Revenue (2014-2016) 12.2.6. India Human Primary Cells Production, Revenue, Consumption (2014-2016) LIST OF TABLES TABLE NO 1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND CAGR (%) COMPARISON BY TYPE (PRODUCT CATEGORY)(2017-2025) TABLE NO 2. HUMAN PRIMARY CELLS CONSUMPTION (MILLION UNITS) COMPARISON BY APPLICATION (2017-2025) TABLE NO 3. GLOBAL HUMAN PRIMARY CELLS MARKET SIZE (VALUE) AND CAGR (%) COMPARISON BY REGION (2017-2025) TABLE NO 4. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) TABLE NO 5. GLOBAL HUMAN PRIMARY CELLS REVENUE ($ MILLION) AND SHARE BY MANUFACTURERS (2017-2025) TABLE NO 6. GLOBAL HUMAN PRIMARY CELLS AVERAGE PRICE BY MANUFACTURERS (2017-2025) TABLE NO 7. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY REGION (2017-2025) TABLE NO 8. GLOBAL HUMAN PRIMARY CELLS REVENUE (VALUE) AND MARKET SHARE BY REGION (2017-2025) TABLE NO 9. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) TABLE NO 10. U.S. HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) TABLE NO 11. EUROPE HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) TABLE NO 12. CHINA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) TABLE NO 13. JAPAN HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) TABLE NO 14. SOUTHEAST ASIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) TABLE NO 15. INDIA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE (2017-2025) TABLE NO 16. GLOBAL HUMAN PRIMARY CELLS PRODUCTION AND MARKET SHARE BY TYPE (2017-2025) TABLE NO 17. GLOBAL HUMAN PRIMARY CELLS REVENUE AND MARKET SHARE BY TYPE (2017-2025) TABLE NO 18. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION AND MARKET SHARE BY APPLICATION (2017-2025) TABLE NO 19. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS TABLE NO 20. LONZA HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025) TABLE NO 21. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS TABLE NO 22. THERMO FISHER SCIENTIFIC HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025) TABLE NO 23. SIGMA-ALDRICH HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025) TABLE NO 24. CURELINE HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025) TABLE NO 25. STEMCELL TECHNOLOGIES HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025) TABLE NO 26. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS TABLE NO 27. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS TABLE NO 28. CHARLES RIVER LABORATORIES HUMAN PRIMARY CELLS PRODUCTION, REVENUE, PRICE AND GROSS MARGIN (2017-2025) TABLE NO 29. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS TABLE NO 30. COMPANY BASIC INFORMATION, MANUFACTURING BASE, SALES AREA AND ITS COMPETITORS TABLE NO 31. KEY SUPPLIERS OF RAW MATERIALS TABLE NO 32. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION, REVENUE FORECAST (2017-2024) TABLE NO 33. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION AND GROWTH RATE FORECAST (2017-2024) TABLE NO 34. U.S. HUMAN PRIMARY CELLS PRODUCTION, REVENUE, FORECAST (2017-2024) TABLE NO 35. EUROPE HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024) TABLE NO 36. CHINA HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024) TABLE NO 37. JAPAN HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024) TABLE NO 38. SOUTHEAST ASIA HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024) TABLE NO 39. INDIA HUMAN PRIMARY CELLS PRODUCTION, REVENUE FORECAST (2017-2024) LIST OF FIGURES FIGURE NO 1. GLOBAL HUMAN PRIMARY CELLS PRODUCTION MARKET SHARE BY TYPE (PRODUCT CATEGORY) IN 2017 FIGURE NO 2. PRODUCT PICTURE OF EPITHELIAL CELLS FIGURE NO 3. PRODUCT PICTURE OF FIBROBLASTS FIGURE NO 4. PRODUCT PICTURE OF HEMATOPOIETIC FIGURE NO 5. PRODUCT PICTURE OF LIVER CELLS FIGURE NO 6. PRODUCT PICTURE OF MESENCHYMAL STEM CELLS FIGURE NO 7. PRODUCT PICTURE OF MUSCLE CELLS FIGURE NO 8. PRODUCT PICTURE OF PERICYTES FIGURE NO 9. U.S. HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025) FIGURE NO 10. EUROPE HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025) FIGURE NO 11. CHINA HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025) FIGURE NO 12. JAPAN HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025) FIGURE NO 13. SOUTHEAST ASIA HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025) FIGURE NO 14. INDIA HUMAN PRIMARY CELLS REVENUE (MILLION USD) AND GROWTH RATE (2017-2025) FIGURE NO 15. GLOBAL HUMAN PRIMARY CELLS REVENUE STATUS AND OUTLOOK (2017-2025) FIGURE NO 16. GLOBAL HUMAN PRIMARY CELLS CAPACITY, PRODUCTION STATUS AND OUTLOOK (2017-2025) FIGURE NO 17. HUMAN PRIMARY CELLS MARKET SHARE OF TOP 3 MANUFACTURERS FIGURE NO 18. HUMAN PRIMARY CELLS MARKET SHARE OF TOP 5 MANUFACTURERS FIGURE NO 19. GLOBAL HUMAN PRIMARY CELLS PRODUCTION BY REGION (2017-2025) FIGURE NO 20. U.S. HUMAN PRIMARY CELLS PRODUCTION (2017-2025) FIGURE NO 21. EUROPE HUMAN PRIMARY CELLS PRODUCTION (2017-2025) FIGURE NO 22. CHINA HUMAN PRIMARY CELLS PRODUCTION (2017-2025) FIGURE NO 23. JAPAN HUMAN PRIMARY CELLS PRODUCTION (2017-2025) FIGURE NO 24. SOUTHEAST ASIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025) FIGURE NO 25. INDIA HUMAN PRIMARY CELLS PRODUCTION (2017-2025) FIGURE NO 26. GLOBAL HUMAN PRIMARY CELLS PRODUCTION GROWTH BY TYPE (2017-2025) FIGURE NO 27. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION GROWTH RATE BY APPLICATION (2017-2025) FIGURE NO 28. MANUFACTURING PROCESS ANALYSIS OF HUMAN PRIMARY CELLS FIGURE NO 29. HUMAN PRIMARY CELLS INDUSTRIAL CHAIN ANALYSIS FIGURE NO 30. GLOBAL HUMAN PRIMARY CELLS REVENUE AND GROWTH RATE FORECAST (2017-2024) FIGURE NO 31. GLOBAL HUMAN PRIMARY CELLS PRICE AND TREND FORECAST (2017-2024) FIGURE NO 32. GLOBAL HUMAN PRIMARY CELLS PRODUCTION FORECAST BY REGION (2017-2024) FIGURE NO 33. GLOBAL HUMAN PRIMARY CELLS PRODUCTION FORECAST BY TYPE (2017-2024) FIGURE NO 34. GLOBAL HUMAN PRIMARY CELLS REVENUE FORECAST BY TYPE (2017-2024) FIGURE NO 35. GLOBAL HUMAN PRIMARY CELLS CONSUMPTION FORECAST BY APPLICATION (2017-2024)

• Lonza
• Thermo Fisher Scientific
• Sigma-Aldrich
• Cell Biologics
• PromoCell GmbH
• Cureline
• Zen-Bio
• Stemcell Technologies
• Pelobiotech

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS